12:00 AM
 | 
Sep 06, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Hylenex: Phase II started

Halozyme began a pair of crossover Phase II trials that will each enroll 110 patients to evaluate insulin aspart with and without rHuPH20, with...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >